Preoperative risk factors of lymph node metastasis in cutaneous squamous cell carcinoma

Journal of Plastic Surgery and Hand Surgery

Volumn 47, Issue 3, 2013, Pages 204-208

  Takeda, Akira ^a   Akimoto, Minekatsu ^a   Nemoto, Mitsuru ^a   Kounoike, Natsuko ^a   Uchinuma, Eiju ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Blue dye technique; Cutaneous squamous cell carcinoma; Local recurrence; Lower lip; Lymph node metastasis; Sentinel lymph node biopsy

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HEAD AND NECK TUMOR; HUMAN; LIP TUMOR; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR INVASION; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LIP NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 84878286409     PISSN: 2000656X     EISSN: None     Source Type: Journal    
DOI: 10.3109/2000656X.2012.750611     Document Type: Article

References (25)

1. Ishihara K, Saida T, Otsuka F, et al. Statical profiles of malignant melanoma and others skin cancers in Japan: 2007 update. Int J Clin Oncol 2008;13:33-41. (Pubitemid 351326291)
2. Rowe DE, Carroll RJ, Day CL Jr, et al. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. J Am Acad Dermatol 1992; 26:976-90.
3. Motley R, Kersey P, Lawrence C, et al. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol 2002;146: 18-25. (Pubitemid 34158404)
4. Motley R, Kersey P, Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Plast Surg 2003;56:85-91. (Pubitemid 36763947)
5. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 2001;344:975-83. (Pubitemid 32240317)
6. Dinehart SM, Pollack SV. Metastases from squamous cell carcinoma of the skin and lip. An analysis of twenty-seven cases. J Am Acad Dermatol 1989;21:241-8. (Pubitemid 19195886)
7. Saida T. Diagnosis of skin malignant tumour, treatment guideline and totalling of national questionnaire. Detailed explanation. B. Skin malignant tumours. 2. Squamous cell carcinoma. (in Japanese). Skin Cancer 1994;9:69-77.
8. Schwartz RA. Verrucous carcinoma of the skin and mucosa. J Am Acad Dermatol 1995;32:1-21.
9. Vandeweyer E, Sales F, Deraemaecker R. Cutaneous verrucous carcinoma. Br J Plast Surg 2001;54:168-70. (Pubitemid 32229345)
10. Jensen P,HansenS, Møller B, et al. Skin cancer in kidney andheart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999;40:177-86. (Pubitemid 29072794)
11. Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002;47:1-17.
12. Teraoka S, Nomoto K, Mito M, et al. Multivariate analyses of factors contributing to early graft function in 759 kidney transplants from non-heart-beating donors. Transplant Proc 2001;33: 1125-6.
13. Teraoka S, Nomoto K, Kikuchi K, et al. Outcomes of kidney transplants from non-heart-beating deceased donors as reported totheJapanOrganTransplantNetworkfromApril1995-December 2003: a multi-center report. Clin Transpl 2004:91-102.
14. Ravanan R, Udayaraj U, Bakran A, et al. Measures of care in adult renal transplant recipients in the United Kingdom (chapter 11). Nephrol Dial Transplant 2007;22:vii138-54.
15. Rudich SM, Kaplan B, Magee JC, et al. Renal transplantations performed using non-heart-beating organ donors: going back to the future? Transplantation 2002;74:1715-20. (Pubitemid 36019325)
16. Cohen B, Smits JM, Haase B, et al. Expanding the donor pool to increase renal transplantation. Nephrol Dial Transplant 2005;20: 34-41. (Pubitemid 40207605)
17. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
18. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001;19:3635-48. (Pubitemid 32786276)
19. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009;27:6199-206.
20. Stoeckli SJ, Steinert H, Pfaltz M, et al. Sentinel lymph node evaluation in squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 2001;125:221-6. (Pubitemid 33662671)
21. Reschly MJ, Messina JL, Zaulyanov LL, et al. Utility of sentinel lymphadenectomy in the management of patients with high-risk cutaneous squamous cell carcinoma. Dermatol Surg 2003;29: 135-40. (Pubitemid 36188419)
22. Wagner JD, Evdokimow DZ, Weisberger E, et al. Sentinel node biopsy for high-risk nonmelanoma cutaneous malignancy. Arch Dermatol 2004;140:75-9. (Pubitemid 38090273)
23. Krag DN,Meijer SJ,Weaver DL, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995;130: 654-8.
24. Gershenwald JE, Thompson W, Mansfield PF, et al. Multiinstitutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999; 17:976-83. (Pubitemid 29109331)
25. Porter GA, Ross MI, Berman RS, et al. How many lymph nodes are enough during sentinel lymphadenectomy for primary melanoma? Surgery 2000;128:306-11. (Pubitemid 30622499)